Advanced Ophthalmology Systems Ltd. – Trademark Portfolio

Entity Type: 03

Advanced Ophthalmology Systems Ltd. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include SPARCA, SPARCA ARTIS, SPARCA MEDICA, and DIGITAL ORGANELLES. The owner is based in Weybridge Surrey.

The Old Rectory

Church Street

Weybridge Surrey KT13DE , GB

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Advanced Ophthalmology Systems Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (5 filings)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Advanced Ophthalmology Systems Ltd. have?

Advanced Ophthalmology Systems Ltd. has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned.

What trademark classes does Advanced Ophthalmology Systems Ltd. file in?

Advanced Ophthalmology Systems Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Advanced Ophthalmology Systems Ltd.'s most well-known trademarks?

Advanced Ophthalmology Systems Ltd.'s registered trademark portfolio includes well-known marks such as SPARCA, SPARCA ARTIS, SPARCA MEDICA, and DIGITAL ORGANELLES. These are among 4 currently registered trademarks in the portfolio.

What is Advanced Ophthalmology Systems Ltd.'s trademark registration success rate?

Advanced Ophthalmology Systems Ltd. has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.